协同抗体中和 SEB 是由体转移体驱动的
Ganggang Bai1, Yanhong Ge1, Yuhong Su1
1Engineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Biophysical journal
|February 22, 2026
概括
协同抗体与葡萄球菌肠毒素B (SEB) 结合,形成一个全性网络,改变蛋白质动态并增强中和. 这涉及变化和溶解效应,对于理解抗体有效性至关重要.
科学领域:
- 结构生物学 结构生物学
- 免疫学 免疫学 免疫学
- 计算生物物理学的计算生物物理学
背景情况:
- 葡萄球菌肠毒素B (SEB) 是一种被抗体中和的毒素,但单个抗体往往缺乏有效性.
- 在SEB上的抗体表位通常远离T细胞受体 (TCR) /MHC-II接口,使中和机制复杂化.
研究的目的:
- 为了研究四级抗体-毒素复合体中的全效应和转移.
- 阐明SEB通过6D3和14G8.8抗体的协同中和背后的分子机制.
主要方法:
- 全原子分子动力学 (MD) 模拟来分析蛋白质动力学和溶解.
- 将分析转移到全网络的地图上.
- 符合性和溶剂的计算.
主要成果:
- 抗体6D3和14G8的同时结合会对SEB产生远程全效应,调节TCR结合区域.
- 建立了一个全性网络,直接影响TCR结合接口.
- 协同抑制与增加的SEB和散到溶剂中的散有关.
结论:
- 环境因素,包括溶解,对于理解质机制至关重要.
- 抗体结合可以通过全oster网络动态调节抗原接口.
- 这项研究提供了关于协同中和和抗体在调节抗原动态中的作用的见解.
更多相关视频
07:08A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021
5.5K
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
1.4K
相关概念视频
Antibody Actions
3.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.1K
Cooperative Allosteric Transitions
9.1K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.1K
Enzyme-Linked Immunosorbent Assay
17.9K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
17.9K
Allosteric Regulation
63.6K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
63.6K
